Mahfuzur Rahman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mahfuzur Rahman has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Rajesh Rajan
Department of Cardiology, Sabah Al Ahmad Cardiac Center, Al Amiri Hospital, Sharq, Kuwait
3 shared publications - Mohammed Al Jarallah
Department of Cardiology, Sabah Al Ahmed Cardiac Centre, Al Amiri Hospital, Kuwait City, Kuwait
2 shared publications - Prashanth Panduranga
Department of Cardiology, National Heart Center, Royal Hospital, Muscat, Sultanate of Oman
2 shared publications - Abdul Monayem
Department of Cardiology Sabah Al Ahmed Cardiac Centre 13001 Kuwait City Kuwait
1 shared publication Fatmah Alzahraa Hussain
Department of Cardiology, Sabah Al Ahmed Cardiac Centre, Al Amiri Hospital, Kuwait City, Kuwait
1 shared publicationGhanimah Aljarallah
Department of Cardiology, Sabah Al Ahmed Cardiac Centre, Al Amiri Hospital, Kuwait City, Kuwait
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wolters Kluwer Health in Annals of Clinical Cardiology
- Vol. 8 (1) , 1-3
The Changing Landscape of Cardiac Electrophysiology
- 1 January 2026
- Published by Wolters Kluwer Health in Annals of Clinical Cardiology
- Vol. 8 (1) , 1-3
Open AccessThe Changing Landscape of Cardiac Electrophysiology
- Open Access
- 1 January 2026
- Published by Wolters Kluwer Health in Annals of Clinical Cardiology
- Vol. 8 (1) , 18-29
Aortic Regurgitation Quantification, Management, and Guidelines: A 2026 Update
We sought to compare recommendations from the European Society of Cardiology and the American College of Cardiology/American Heart Association guidelines, for the diagnosis and management of aortic regurgitation (AR), a major cause of valvular heart disease. Both guidelines agreed on a multidisciplinary approach to grade the mechanism and severity of AR. In both guidelines, surgical aortic valve (AV) replacement remains the predominant treatment modality after the surgical risk profile has been determined. Trans-catheter AV implantation is an alternative, but further data are needed to determine its efficacy. This review article focuses on AR and describes the prevalence, mechanisms, diagnosis, and treatment of AR.
- 1 January 2026
- Published by Wolters Kluwer Health in Annals of Clinical Cardiology
- Vol. 8 (1) , 18-29
Open AccessAortic Regurgitation Quantification, Management, and Guidelines: A 2026 Update
We sought to compare recommendations from the European Society of Cardiology and the American College of Cardiology/American Heart Association guidelines, for the diagnosis and management of aortic regurgitation (AR), a major cause of valvular heart disease. Both guidelines agreed on a multidisciplinary approach to grade the mechanism and severity of AR. In both guidelines, surgical aortic valve (AV) replacement remains the predominant treatment modality after the surgical risk profile has been determined. Trans-catheter AV implantation is an alternative, but further data are needed to determine its efficacy. This review article focuses on AR and describes the prevalence, mechanisms, diagnosis, and treatment of AR.
- Top Cited PapersOpen Access
- 19 February 2025
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 20 (1) , 15
Cardiovascular Effects of Smoking and Smoking Cessation: A 2024 Update
Smoking is a significant risk factor for both acute and chronic cardiovascular diseases. These diseases contribute to approximately twenty percent of all-cause mortality. Research indicates that quitting smoking can substantially reduce or even reverse the harmful effects associated with smoking on cardiovascular health. Notably, these benefits can be observed in a relatively short period compared to the duration of smoking history. This article aims to provide data to understand the effects of smoking on the cardiovascular system locally as well as its effects as a pandemic globally and hence provide comprehensive strategies in the management of cardiovascular patients for smoking cessation.
- 19 February 2025
- Published by Ubiquity Press, Ltd. in Global Heart
- Vol. 20 (1) , 15
Top Cited PapersOpen AccessCardiovascular Effects of Smoking and Smoking Cessation: A 2024 Update
Smoking is a significant risk factor for both acute and chronic cardiovascular diseases. These diseases contribute to approximately twenty percent of all-cause mortality. Research indicates that quitting smoking can substantially reduce or even reverse the harmful effects associated with smoking on cardiovascular health. Notably, these benefits can be observed in a relatively short period compared to the duration of smoking history. This article aims to provide data to understand the effects of smoking on the cardiovascular system locally as well as its effects as a pandemic globally and hence provide comprehensive strategies in the management of cardiovascular patients for smoking cessation.